StockOtters
StockOttersSupply Chain Map
Beijing Tiantan Biological Products Co., Ltd. logo

Beijing Tiantan Biological Products Co., Ltd.

600161.SS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
844
Cost of Revenue
383
Gross Profit
461
Gross Margin
54.6%
Operating Income
358
Operating Margin
42.4%
Net Income
217
Net Margin
25.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
389
EBITDA Margin
46.0%

2023

12/31/2023

Revenue
725
Cost of Revenue
357
Gross Profit
368
Gross Margin
50.7%
Operating Income
253
Operating Margin
34.8%
Net Income
155
Net Margin
21.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
274
EBITDA Margin
37.7%

2022

12/31/2022

Revenue
597
Cost of Revenue
304
Gross Profit
292
Gross Margin
49.0%
Operating Income
200
Operating Margin
33.6%
Net Income
123
Net Margin
20.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
203
EBITDA Margin
34.1%

2021

12/31/2021

Revenue
576
Cost of Revenue
302
Gross Profit
274
Gross Margin
47.5%
Operating Income
174
Operating Margin
30.3%
Net Income
106
Net Margin
18.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
184
EBITDA Margin
31.9%

2020

12/31/2020

Revenue
482
Cost of Revenue
245
Gross Profit
237
Gross Margin
49.2%
Operating Income
155
Operating Margin
32.1%
Net Income
89
Net Margin
18.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
165
EBITDA Margin
34.3%